Reuters logo
12 天前
BRIEF-Medicines Co reports Q2 GAAP loss per share $5.52 from continuing operations
2017年8月9日 / 中午11点34分 / 12 天前

BRIEF-Medicines Co reports Q2 GAAP loss per share $5.52 from continuing operations

Aug 9 (Reuters) - Medicines Co

* The Medicines Company reports second quarter 2017 business and financial results

* Q2 GAAP loss per share $5.52 from continuing operations

* Q2 revenue $18.7 million versus $54.7 million

* Q2 earnings per share view $-1.96 -- Thomson Reuters I/B/E/S

* Q2 revenue view $28.4 million -- Thomson Reuters I/B/E/S

* Q2 adjusted non-GAAP loss per share $1.02 from continuing operations Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below